Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cheng, L.
Right arrow Articles by Glasier, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, L.
Right arrow Articles by Glasier, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 15, No. 9, 1969-1972, September 2000
© 2000 European Society of Human Reproduction and Embryology

Once a month administration of mifepristone improves bleeding patterns in women using subdermal contraceptive implants releasing levonorgestrel

L. Cheng1, H. Zhu1, A. Wang2, F. Ren1, J. Chen1 and A. Glasier3,4

1 Shanghai Institute of Family Planning Technical Instruction, International Peace Maternity and Child Health Hospital, 2 Jiaxing Reproduction Health Care Centre, Shanghai, People's Republic of China and 3 University of Edinburgh, Department of Obstetrics and Gynaecology, Edinburgh, UK

It has been suggested that the administration of an anti-progesterone might improve bleeding patterns in women with irregular bleeding while using low-dose progestin-only contraception. We report the findings of a double-blind, randomized, placebo-controlled trial of mifepristone 50 mg taken once every 4 weeks in 100 Chinese women (50 subjects and 50 controls) complaining of frequent and irregular bleeding while using a levonorgestrel-releasing subdermal contraceptive implant. In all women, regardless of treatment, the frequency of bleeding decreased significantly over 360 days of observation. Women recorded significantly shorter episodes of bleeding (P < 0.0002) during mifepristone treatment than during the 90 days before treatment started. In contrast, the duration of bleeding episodes fell more gradually in placebo-treated controls. Women using mifepristone were more likely to find treatment acceptable than women receiving a placebo tablet (P < 0.01). Despite concern that anti-progestogenic effects may jeopardize contraception, there were no pregnancies. This approach may offer a useful strategy to improve continuation rates by alleviating unwanted side-effects until bleeding patterns improve spontaneously with time.

Key words: bleeding/contraception/implants/mifepristone/progestin-only

4 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, University of Edinburgh Centre for Reproductive Biology, 37 Chalmers Street, Edinburgh EH3 9ET, UK. E-mail: a.glasier{at}ed.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ReproductionHome page
N. B Morison, T. J Kaitu'u-Lino, I. S Fraser, and L. A Salamonsen
Stimulation of epithelial repair is a likely mechanism for the action of mifepristone in reducing duration of bleeding in users of progestogen-only contraceptives
Reproduction, August 1, 2008; 136(2): 267 - 274.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
F. M. Horne and D. L. Blithe
Progesterone receptor modulators and the endometrium: changes and consequences
Hum. Reprod. Update, November 1, 2007; 13(6): 567 - 580.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. K. Jain, A. Li, W. Yang, P. Minoo, and J. C. Felix
Effects of mifepristone on proliferation and apoptosis of human endometrium in new users of medroxyprogesterone acetate
Hum. Reprod., March 1, 2006; 21(3): 798 - 809.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. Weisberg, M. Hickey, D. Palmer, V. O'Connor, L.A. Salamonsen, J.K. Findlay, and I.S. Fraser
A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon
Hum. Reprod., January 1, 2006; 21(1): 295 - 302.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Li, J.C. Felix, J. Hao, P. Minoo, and J.K. Jain
Menstrual-like breakdown and apoptosis in human endometrial explants
Hum. Reprod., June 1, 2005; 20(6): 1709 - 1719.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
N. Chabbert-Buffet, G. Meduri, P. Bouchard, and I. M. Spitz
Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications
Hum. Reprod. Update, May 1, 2005; 11(3): 293 - 307.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
K. Gemzell-Danielsson, A.M. van Heusden, S.R. Killick, H.B. Croxatto, P. Bouchard, S. Cameron, and M. Bygdeman
Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen
Hum. Reprod., October 1, 2002; 17(10): 2588 - 2593.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.